FDA Investigator Rachael A Moliver

Rachael A Moliver has inspections in 4 countries as of 19 Sep 2023. Rachael A Moliver has collaborated with a combinined 2437 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
37
Last Inspection Date:
19 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100004570
Country:
United States of America, Israel, Italy, Switzerland
Co-Investigator(s):
Adam R Cooke, Alice S Tsao, Althea A Williams, Amatul H Marium, Arduino Frankovic, Ashley Polizzotto, Bijoy Panicker, Bonita S Chester, Brandy N Lepage, Brett D Weed, Brett Weed, Carrie E Jolly, Cassandra L Abellard, Charisse K Green, Christian Parra, Claire O Nicholls, Constance Y Fears, Danna E Solorzano, Dave M Deroche, David K Lau, David R Delucia, Debra L Pagano, Demitria J Xiradakis, Devon Jenkins, Dongping Dai, PhD, Douglas G Ng, Dr. Jason R Caballero, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edward Lukeman, Edwin Melendez, Erik W Koester, Evelyn Taha, Felix Maldonado, Frank Verni, Gary J Lehr, Gavin T Cua, Gideon N Esuzor, Guerlain Ulysse, Herbert M Corbello, Iram R Hassan, PhD, Jackson Y See, Jacob G Lutz, Jacqueline S Warner, James A Liubicich, James C Maclaughlin, James D Bridges, Jason F Chancey, Jawaid Hamid, Jay T Wong, John P Mistler, Johnna L Bleem, Jonah S Ufferfilge, Jose O Hernandez, Jose Ohernandez Guzman, Joseph Maselli, Juan Rjimenez Garcia, Junho Pak, Kames A Liubicich, Karen L Kosar, Karishma G Gopaul, Katie L Penno, Kenneth H Williams, Khalid M Khan, Kim Lthomas Cruse, Kim Thomasc Rice, Kwong P Lee, Lance M De Souza, MBA, Laurimer Kuilan Torres, Lawrence W Farina, LCDR Chad N Thompson, Liatte Kreuger, PharmD, Lori M Newman, Luis A Dasta, Melanie M Walker, Meredith P Soehl, Investigator, Michael A Charles, Michael D Omeara, Michael E Maselli, Michael W Burd, Mindy M Chou, Miral B Patel, Mra M Barbosar, Nancy F Scheraga, Neil J Bonzagni, PhD MPH, Niketa Patel, Noreen Muniz, Parul M Patel, Patrick C Klotzbuecher, Paul L Figarole, Jr, Paul Mouris, Penny H Mccarver, Peter Abel, Peter Caparelli, Peter R Caparelli, Peter S Diak, Philip F Istafanos, DMV, MS, Phyllis J Wilson, Pushpa S Jayasekara, Raymond M Lam, Regina T Brown, Richard H Penta, Robert C Steyert, Rochelle K Kimmel, Rose Xu, Russell J Glapion, Salvatore N Randazzo, Samantha J Bradley, Samina S Khan, Samir C Gala, Samuel T Walker, Sean R Marcsisin, Seneca D Toms, Shantel S Brown, Simone E Pitts, Sony Mathews, Sonya M Edmonds, State Agency, Syeda N Mahazabin, Tamara M Simpson, Tara K Carmody, Tara K Normandin, Tekalign Wondimu, Theresa Kirkham (NMI), Thomas J Mooney, Tonia F Bernard, Tracy M Portelli, Tracy R Ball, Tressa T Lewis, Uduak M Inokon, Vaishali J Patel, Victoria Spivak, Vilmary Negron Rodriguez, Viviana Matta, Vivin George, Xiomara Copeland, Yuyan Liang, Yvesna C Blaise, Yvette I Henry, Yvette I Johnson

Rachael A Moliver's Documents

Publish Date Document Type Title
July, 2019 FDA 483 Maimonides Medical Center - Pharmacy - Form 483, 2019-07-29
December, 2015 FDA 483 Misonix, Inc. - Form 483, 2015-12-14
April, 2019 FDA 483 Metro Drugs 3rd Avenue Corp - Form 483, 2019-04-05
March, 2016 FDA 483 MSKCC RMIPC - Form 483, 2016-03-29
January, 2016 FDA 483 Topiderm, Inc. - Form 483, 2016-01-21
November, 2019 FDA 483 Response Life Science Pharmacy Inc - Form 483R, 2019-12-11
April, 2018 FDA 483 Pine Pharmaceuticals, LLC - Form 483, 2018-04-26
June, 2018 EIR Haupt Pharma Latina S.r.l. - EIR, 2018-06-28
September, 2017 FDA 483 Exela Pharma Sciences, LLC. - Form 483, 2017-09-28
September, 2019 FDA 483 Peer Pharm Ltd. - Form 483, 2019-09-11
December, 2015 FDA 483 Advance Pharmaceutical, Inc. - Form 483, 2015-12-02
May, 2017 FDA 483 Amneal Pharmaceuticals of New York, LLC - Form 483, 2017-05-24
June, 2018 FDA 483 Haupt Pharma Latina S.r.l. - Form 483, 2018-06-28
January, 2018 EIR DSM Nutritional Products AG Zweigniederlassung Werk Sisseln - EIR, 2018-01-25
November, 2017 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2017-11-15
December, 2016 FDA 483 Magellan Rx Pharmacy, LLC - Form 483, 2016-12-22
March, 2017 FDA 483 SterRx, LLC - Form 483, 2017-03-17
September, 2018 FDA 483 Kings Park Slope Inc - Form 483, 2018-09-14
November, 2016 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2016-11-10
January, 2020 FDA 483 Tekweld Solutions, Inc. - Form 483, 2020-01-17
August, 2016 FDA 483 Aurora Labs, LLC - Form 483, 2016-08-10
November, 2019 FDA 483 Life Science Pharmacy Inc - Form 483, 2019-11-20
December, 2017 FDA 483 Athenex Pharma Solutions, LLC - Form 483, 2017-12-13
April, 2019 EIR Metro Drugs 3rd Avenue Corp - EIR, 2019-04-05
June, 2017 FDA 483 Buffalo Pharmacies Inc - Form 483, 2017-06-23
March, 2018 FDA 483 Edge Pharma, LLC - Form 483, 2018-03-08

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more